Australia markets open in 9 hours 18 minutes

Cartesian Therapeutics, Inc. (RNAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.97-0.65 (-3.69%)
At close: 04:00PM EDT
16.80 -0.17 (-1.00%)
After hours: 07:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,906
26,004
110,777
85,077
16,597
Operating expenses
Research development
62,953
71,839
72,377
68,736
54,505
Selling general and administrative
44,336
40,581
23,862
20,938
18,913
Total operating expenses
107,289
112,420
96,239
89,674
73,418
Operating income or loss
-81,383
-86,416
14,538
-4,597
-56,821
Interest expense
2,025
2,833
3,031
2,844
1,556
Total other income/expenses net
-190,463
-149,461
23,263
-2,280
-10,499
Income before tax
-273,871
-238,710
34,770
-9,721
-68,876
Income tax expense
-
-19,000
-609
15,966
0
Income from continuing operations
-254,871
-219,710
35,379
-25,687
-68,876
Net income
-254,871
-219,710
35,379
-25,687
-68,876
Net income available to common shareholders
-254,871
-219,710
35,379
-25,687
-68,876
Basic EPS
-0.24
-49.80
7.20
-6.60
-20.40
Diluted EPS
-0.32
-49.80
3.00
-6.60
-20.40
Basic average shares
153,685
5,170
4,825
3,811
3,373
Diluted average shares
153,685
5,170
4,862
3,811
3,373